6
Clinical Trials associated with CU-20401A Phase 2 Clinical Study to Evaluate the Efficacy and Safety of CU-20401 for Injection in Moderate to Severe Contour Protuberance or Excessive Enrichment Due to Submental Fat (SMF) Accumulation
This is a randomized, double-blind, placebo-controlled Phase Ⅱ clinical study to evaluate the efficacy, safety, and immunogenicity of CU-20401 for Injection in a population with moderate to severe contour elevation or over-fullness due to SMF accumulation.
评价注射用CU-20401在颏下脂肪(SMF)堆积造成的中度至重度轮廓隆起或过度丰满人群中的有效性和安全性的II期临床研究
[Translation] A Phase II clinical study to evaluate the efficacy and safety of CU-20401 for injection in people with moderate to severe contour bulge or excessive fullness caused by submental fat (SMF) accumulation
主要研究目的:评价注射用CU-20401在SMF堆积造成的中度至重度轮廓隆起或过度丰满人群中的有效性。
次要研究目的:评价注射用CU-20401在SMF堆积造成的中度至重度轮廓隆起或过度丰满人群中的安全性;评价注射用CU-20401在SMF堆积造成的中度至重度轮廓隆起或过度丰满人群中的免疫原性。
[Translation] Primary study objective: To evaluate the effectiveness of CU-20401 for injection in people with moderate to severe contour bulge or excessive fullness caused by SMF accumulation.
Secondary study objectives: To evaluate the safety of CU-20401 for injection in people with moderate to severe contour bulge or excessive fullness caused by SMF accumulation; To evaluate the immunogenicity of CU-20401 for injection in people with moderate to severe contour bulge or excessive fullness caused by SMF accumulation.
a Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401 Administered Subcutaneously in the Submental Fat (SMF) Population
This study is a Phase Ib/II clinical study. Phase 1b was a single-center, nonrandomized, single-arm study to evaluate the safety, PK profile, preliminary efficacy, and immunogenicity of different groups (SC) of CU-20401 in the submental fat accumulation population. Phase 2 is a multicenter, randomized, placebo parallel-controlled study to evaluate the safety, efficacy, and immunogenicity of the preferred group (SC) of CU-20401 in a submental fat accumulation population.
100 Clinical Results associated with CU-20401
100 Translational Medicine associated with CU-20401
100 Patents (Medical) associated with CU-20401
100 Deals associated with CU-20401